The Gut Microbiota Modulates Neuroinflammation in Alzheimer's Disease: Elucidating Crucial Factors and Mechanistic Underpinnings
Jianshe Yang,Junyi Liang,Niyuan Hu,Ningjuan He,Bin Liu,Guoliang Liu,Ying Qin
DOI: https://doi.org/10.1111/cns.70091
2024-10-28
CNS Neuroscience & Therapeutics
Abstract:Imbalance in the gut microbiota triggers neuroinflammation, thereby promoting the progression of Alzheimer's disease. Modulating the gut microbiota may reverse this process, offering a new strategy for the treatment of AD. Such interventions through the gut–brain axis pave new avenues for the prevention and treatment of AD. This figure was created with BioRender.com. Background and Purpose Alzheimer's disease (AD) is characterized by progressive cognitive decline and neuronal loss, commonly linked to amyloid‐β plaques, neurofibrillary tangles, and neuroinflammation. Recent research highlights the gut microbiota as a key player in modulating neuroinflammation, a critical pathological feature of AD. Understanding the role of the gut microbiota in this process is essential for uncovering new therapeutic avenues and gaining deeper insights into AD pathogenesis. Methods This review provides a comprehensive analysis of how gut microbiota influences neuroinflammation and glial cell function in AD. A systematic literature search was conducted, covering studies from 2014 to 2024, including reviews, clinical trials, and animal studies. Keywords such as "gut microbiota," "Alzheimer's disease," "neuroinflammation," and "blood–brain barrier" were used. Results Dysbiosis, or the imbalance in gut microbiota composition, has been implicated in the modulation of key AD‐related mechanisms, including neuroinflammation, blood–brain barrier integrity, and neurotransmitter regulation. These disruptions may accelerate the onset and progression of AD. Additionally, therapeutic strategies targeting gut microbiota, such as probiotics, prebiotics, and fecal microbiota transplantation, show promise in modulating AD pathology. Conclusions The gut microbiota is a pivotal factor in AD pathogenesis, influencing neuroinflammation and disease progression. Understanding the role of gut microbiota in AD opens avenues for innovative diagnostic, preventive, and therapeutic strategies.
pharmacology & pharmacy,neurosciences